Published in

Nature Research, Nature Genetics, 5(41), p. 602-608, 2009

DOI: 10.1038/ng.358

Links

Tools

Export citation

Search in Google Scholar

A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Loss-of-function mutations in the FLG (filaggrin) gene cause the semidominant keratinizing disorder ichthyosis vulgaris(1) and convey major genetic risk for atopic dermatitis (eczema)(2-4), eczema-associated asthma(2,3) and other allergic phenotypes(5). Several low-frequency FLG null alleles occur in Europeans and Asians, with a cumulative frequency of similar to 9% in Europe(4). Here we report a 1-bp deletion mutation, 5303delA, analogous to common human FLG mutations, within the murine Flg gene in the spontaneous mouse mutant flaky tail (ft). We demonstrate that topical application of allergen to mice homozygous for this mutation results in cutaneous inflammatory infiltrates and enhanced cutaneous allergen priming with development of allergen-specific antibody responses. These data validate flaky tail as a useful model of filaggrin deficiency and provide experimental evidence for the hypothesis that antigen transfer through a defective epidermal barrier is a key mechanism underlying elevated IgE sensitization and initiation of cutaneous inflammation in humans with filaggrin-related atopic disease.